Mater Dei Hospital has taken an important step forward in the field of medical imaging with a substantial one-million-euro investment in cutting-edge equipment and technology. This investment has facilitated the launch of a new SPECT-CT scanning service, further enriching the already extensive array of specialised services offered by the Radiology Department at the hospital.

The introduction of this advanced technology is set to make substantial impact on patient care. By enabling specialists to detect conditions and illnesses with greater precision, this equipment allows for more accurate and detailed diagnoses. As a result, patients can benefit from effective and timely treatment, tailored to their specific needs.

SPECT, or Single Photon Emission Computed Tomography, is a sophisticated imaging technique that employs a radioactive substance and a specialised camera to produce three-dimensional images. Unlike many other imaging tests that primarily display the structural appearance of internal organs, a SPECT scan provides crucial insights into the functional aspects of these organs. For instance, it can reveal how efficiently blood is circulating to the heart, identify areas of the brain that are more or less active, or determine which parts of the bones are affected by cancer. Such detailed information is invaluable in guiding treatment decisions and improving patient outcomes.

During the launch of the new equipment, the Minister for Health and Active Ageing, Jo Etienne Abela, highlighted its versatility across various medical fields, including orthopaedics, endocrinology, pulmonology, cardiology, and oncology. This versatility highlights the wide-reaching benefits of the technology, which will be utilised to enhance care across multiple specialities.

In a parallel development, the Sir Anthony Mamo Oncology Hospital has also embraced innovative technology with the recent introduction of MR Linac technology. This state-of-the-art device has been in use since the beginning of the month, marking a new era in radiation therapy. The MR Linac enables healthcare professionals to monitor and adjust treatment in real-time while the patient is receiving radiation therapy. This capability ensures that the therapy is not only more precise but also more effective, minimising the risk of damage to surrounding healthy tissues and organs. Already, three prostate cancer patients have successfully undergone this advanced treatment since its implementation.

These investments in advanced medical technologies at Mater Dei Hospital and Sir Anthony Mamo Oncology Hospital represent a commitment to improving patient care through innovation. By adopting such cutting-edge tools, these institutions are setting new standards in diagnostic and therapeutic practices, ultimately making a difference in the lives of patients who find themselves at the critical juncture between life and death.